Source:http://linkedlifedata.com/resource/pubmed/id/15288309
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2004-8-3
|
| pubmed:abstractText |
The PEARLS study prospectively monitored selected nosocomial pathogens from 38 centres in 13 European, three Middle Eastern countries and South Africa during 2001-2002. Extended spectrum beta-lactamase (ESBL) production rates among Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp. were 5.4% (142/2609), 18.2% (401/2,206) and 8.8% (204/2,328), respectively, for all study sites. The overall ESBL production rate for the combined Enterobacteriaceae was 10.5% (747/7,143), highest in Egypt, 38.5%, and Greece, 27.4%, and lowest in The Netherlands, 2.0%, and Germany, 2.6%. IEF, PCR and DNA sequencing determined 10.7% false positives among Enterobacter spp. when using NCCLS guidelines to screen for ESBL production. The prevalence of nosocomial methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium was 32.4% (294/908) and 8.7% (83/949), respectively. PEARLS provides baseline data against which prospective changes in resistant determinants and outcomes can be measured in this ongoing study.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0924-8579
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
24
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
119-24
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:15288309-Anti-Bacterial Agents,
pubmed-meshheading:15288309-Cross Infection,
pubmed-meshheading:15288309-Enterobacteriaceae,
pubmed-meshheading:15288309-Enterobacteriaceae Infections,
pubmed-meshheading:15288309-Enterococcus faecium,
pubmed-meshheading:15288309-Europe,
pubmed-meshheading:15288309-Gram-Positive Bacterial Infections,
pubmed-meshheading:15288309-Humans,
pubmed-meshheading:15288309-Incidence,
pubmed-meshheading:15288309-Methicillin Resistance,
pubmed-meshheading:15288309-Microbial Sensitivity Tests,
pubmed-meshheading:15288309-Middle East,
pubmed-meshheading:15288309-Population Surveillance,
pubmed-meshheading:15288309-South Africa,
pubmed-meshheading:15288309-Staphylococcus aureus,
pubmed-meshheading:15288309-Vancomycin Resistance,
pubmed-meshheading:15288309-beta-Lactamases
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.
|
| pubmed:affiliation |
Laboratories International for Microbiology Studies, 2122 Palmer Road, Schaumburg, IL 60173-3817, USA. sambouchillon@comcast.net
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|